FDAapproval84% confidence
FDA Listing of Authorized Generics
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to Micro Labs; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Cardiovascular · Anticoagulant
- Sub-indication
- General
Related signal: FDA Grants Approval for Rivaroxaban Generic by Micro Labs